This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jan;62(1):54-5.

doi: 10.1016/j.ijtb.2015.02.029. Epub 2015 Mar 14.

Response to Dr Daley's article: Do not ignore the private sector

Radhika Banka¹, Zarir Udwadia²

Affiliations

Affiliations

¹ DNB Trainee, Department of Pulmonary Medicine, P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400016, India. Electronic address: radhika.banka@gmail.com.
² Consultant, Department of Pulmonary Medicine, P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400016, India.

PMID: 25857568
DOI: 10.1016/j.ijtb.2015.02.029

Comment

Response to Dr Daley's article: Do not ignore the private sector

Radhika Banka et al. Indian J Tuberc. 2015 Jan.

. 2015 Jan;62(1):54-5.

doi: 10.1016/j.ijtb.2015.02.029. Epub 2015 Mar 14.

Authors

Radhika Banka¹, Zarir Udwadia²

Affiliations

¹ DNB Trainee, Department of Pulmonary Medicine, P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400016, India. Electronic address: radhika.banka@gmail.com.
² Consultant, Department of Pulmonary Medicine, P D Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400016, India.

PMID: 25857568
DOI: 10.1016/j.ijtb.2015.02.029

No abstract available

PubMed Disclaimer

Comment on

Global scale-up of the programmatic management of multidrug-resistant tuberculosis.
Daley CL. Daley CL. Indian J Tuberc. 2014 Apr;61(2):108-15. Indian J Tuberc. 2014. PMID: 25509932 Review.

Similar articles

Global scale-up of the programmatic management of multidrug-resistant tuberculosis.
Daley CL. Daley CL. Indian J Tuberc. 2014 Apr;61(2):108-15. Indian J Tuberc. 2014. PMID: 25509932 Review.
High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public-private initiative.
Villegas SL, Ferro BE, Perez-Velez CM, Moreira CA, Forero L, Martínez E, Rastogi N, Caminero JA. Villegas SL, et al. Eur Respir J. 2012 Dec;40(6):1569-72. doi: 10.1183/09031936.00018212. Eur Respir J. 2012. PMID: 23204023 No abstract available.
[Multidrug resistance tuberculosis - current problems].
Kruczak K, Nizankowska-Mogilnicka E. Kruczak K, et al. Pneumonol Alergol Pol. 2009;77(3):276-83. Pneumonol Alergol Pol. 2009. PMID: 19591099 Review. Polish.
'Universal' access for MDR-TB limited without the involvement of the private sector.
Pinto L, Udwadia Z. Pinto L, et al. Int J Tuberc Lung Dis. 2011 Jun;15(6):851; author reply 851-2. doi: 10.5588/ijtld.10.0714. Int J Tuberc Lung Dis. 2011. PMID: 21575312 No abstract available.
Progress towards TB reduction targets is faltering, report finds.
Cousins S. Cousins S. BMJ. 2017 Oct 13;359:j4758. doi: 10.1136/bmj.j4758. BMJ. 2017. PMID: 29030533 No abstract available.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information